Human Metabolome Technologies Inc (6090)

Currency in JPY
779.0
0.0(0.00%)
Closed·
6090 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6090 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
778.0794.0
52 wk Range
564.0869.0
Key Statistics
Bid/Ask
778.00 / 784.00
Prev. Close
779
Open
788
Day's Range
778-794
52 wk Range
564-869
Volume
19.7K
Average Volume (3m)
12.09K
1-Year Change
41.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6090 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Human Metabolome Technologies Inc Company Profile

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.

Compare 6090 to Peers and Sector

Metrics to compare
6090
Peers
Sector
Relationship
P/E Ratio
14.2x11.2x−0.5x
PEG Ratio
1.180.080.00
Price/Book
2.2x1.7x2.6x
Price / LTM Sales
3.0x2.5x3.3x
Upside (Analyst Target)
-8.2%43.5%
Fair Value Upside
Unlock11.5%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 53.98%
Dividend Yield
1.93%
Industry Median 2.57%
Annualised payout
15.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

6090 Income Statement

FAQ

What Stock Exchange Does Human Metabolome Tech Trade On?

Human Metabolome Tech is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Human Metabolome Tech?

The stock symbol for Human Metabolome Tech is "6090."

What Is the Human Metabolome Tech Market Cap?

As of today, Human Metabolome Tech market cap is 4.52B.

What Is Human Metabolome Tech's Earnings Per Share (TTM)?

The Human Metabolome Tech EPS (TTM) is 53.98.

When Is the Next Human Metabolome Tech Earnings Date?

Human Metabolome Tech will release its next earnings report on 06 Nov 2025.

From a Technical Analysis Perspective, Is 6090 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Human Metabolome Tech Stock Split?

Human Metabolome Tech has split 0 times.

How Many Employees Does Human Metabolome Tech Have?

Human Metabolome Tech has 58 employees.

What is the current trading status of Human Metabolome Tech (6090)?

As of 09 Aug 2025, Human Metabolome Tech (6090) is trading at a price of 779.00, with a previous close of 779.00. The stock has fluctuated within a day range of 778.00 to 794.00, while its 52-week range spans from 564.00 to 869.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.